Cagrilintide 10mg UK | Research Grade Amylin Analogue

Name: Cagrilintide 10mg
Brand: Nova Biolabs
Price: 45.00 GBP
Availability: InStock

Overview

Cagrilintide is a long-acting amylin receptor agonist — an acylated analogue of human amylin, the hormone co-secreted with insulin by pancreatic beta cells. The fatty acid modification promotes albumin binding, extending its half-life and supporting once-weekly dosing schedules in research protocols, using the same acylation approach seen in long-acting GLP-1 analogues.

Unlike GLP-1 receptor agonists such as semaglutide or tirzepatide, Cagrilintide acts on amylin receptors, engaging a distinct but complementary signalling pathway relevant to appetite regulation and gastric emptying research. It is frequently studied in combination with GLP-1 receptor agonists to investigate additive or synergistic effects across the two pathways.

Nova Biolabs supplies Cagrilintide 10mg in lyophilised form from UK domestic stock.

Key Research Areas

Amylin Receptor Signalling

Cagrilintide's design as a stable, long-acting amylin analogue makes it a useful tool for studying amylin receptor activation independently of GLP-1 pathway involvement.

Gastric Emptying Research

Amylin signalling is studied for its role in slowing gastric emptying, a mechanism relevant to satiety and post-prandial glucose research models.

Combined GLP-1 / Amylin Pathway Studies

Cagrilintide is widely investigated alongside GLP-1 receptor agonists to explore whether dual-pathway engagement produces additive effects in appetite regulation research.

Acylation & Half-Life Research

As an acylated peptide, Cagrilintide is a relevant reference compound for pharmacokinetic and albumin-binding research within long-acting peptide design.

Product Specifications

Format	Lyophilised powder
Quantity	10mg per vial
Grade	Research Grade
Storage	Refrigerate at 2–8°C, protected from light. Stable 24 months lyophilised.
Origin	UK domestic stock
Research use	In vitro / laboratory use only

Frequently Asked Questions

What is Cagrilintide?

Cagrilintide is a long-acting amylin receptor agonist. It is an acylated analogue of human amylin, a hormone co-secreted with insulin by pancreatic beta cells, modified with a fatty acid chain to extend its half-life and support once-weekly dosing in research protocols.

How does Cagrilintide differ from GLP-1 receptor agonists like semaglutide or tirzepatide?

Cagrilintide acts on amylin receptors rather than GLP-1 receptors. Amylin signalling slows gastric emptying and acts on satiety centres in the hindbrain (notably the area postrema), a distinct but complementary pathway to incretin-based GLP-1 signalling. This is why the two mechanisms are frequently studied together.

Is Cagrilintide studied in combination with other peptides?

Yes. Cagrilintide is widely studied alongside GLP-1 receptor agonists, most notably semaglutide, to investigate whether combining amylin and GLP-1 pathway signalling produces additive effects on appetite regulation research models.

How should Cagrilintide 10mg be stored?

Store lyophilised at 2–8°C, protected from light. Stable for up to 24 months lyophilised. Once reconstituted, use within 28 days.

Do you stock Cagrilintide in the UK?

Yes. Nova Biolabs holds Cagrilintide 10mg in UK domestic stock for fast, discreet dispatch across the UK.

Commonly Stacked With

Compounds researchers often study alongside this one, and why.

Semaglutide 10mg

From £20.00

Amylin and GLP-1 receptor pathways are frequently studied together — Cagrilintide is often paired with a GLP-1 agonist for combined appetite-signalling research.